Pharma

US FDA makes 2 observations for Caplin’s sterile injectable site in Chennai

Read more

Opportunity for Indian pharma industry to capitalise on escalating US-China trade war: GlobalData

Read more

A silver lining to withdrawal of GSP benefits?

Read more

25 batches of drugs of 18 pharma companies found substandard since January 2018 by BPPI

Read more

Digital era of drug development

Read more

Biocon’s biologics facilities in Bengaluru received GMP compliance certificate from EMA

Read more

Univercells granted $14.3 mn to deliver affordable measles and rubella vaccines

Read more

Sun Pharma announces Late-Breaking Phase 2 data showing potential of ILUMYA (tildrakizumab-asmn)

Read more

DRL to sell neurology branded products to Upsher-Smith Laboratories

Read more

‘The Future of Supply Chain Management’ by OPPI

Read more